Superior Stability Secured by a Four-Phase Cathode Electrolyte Interface on a Ni-Rich Cathode for Lithium Ion Batteries.

A multifunctional coating with high ionic and electronic conductivity is constructed on the surface of LiNi0.8Co0.1Mn0.1O2 (NCM) to boost the battery stability upon cycling and during storage as well. Phosphoric acid reacts with residual lithium species on the pristine NCM to form a Li3PO4 coating with extra carbon nanotubes (CNTs) penetrating through, which shows high ionic and electronic conductivity. NCM, Li3PO4, CNTs, and the electrolyte jointly form a four-phase cathode electrolyte interface, which plays a key role in the great enhancement of capacity retention, from 50.3% for pristine NCM to 84.8% for the modified one after 500 cycles at 0.5C at room temperature. The modified NCM also delivers superior electrochemical performances at a high cut-off voltage (4.5 V), high temperature (55 °C), and high rate (10C). Furthermore, it can deliver 154.2 mA h g-1 at the 500th cycle after exposed to air with high humidity for 2 weeks. These results demonstrate that the well-constructed multifunctional coating can remarkably enhance the chemical and electrochemical performances of NCM. The improved cycling, storage, and rate performance are attributed to the four-phase cathode electrolyte interface delivering high electron and ionic conductivity and securing the cathode against attack. This work broadens the horizon for constructing effective electrode/electrolyte interfaces for electrochemical energy storage and conversion

Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review

Since the outbreak of the novel coronavirus disease 2019 (COVID-19) in 2019, many countries have successively developed a variety of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, with the continuous spread of SARS-CoV-2, it has evolved several variants; as a result, prevention and control of the pandemic of SARS-CoV-2 has become more important. Among these variants, the Omicron variant has higher transmissibility and immune escape ability and is the main variant causing a large number of COVID-19 breakthrough infection, thus, presenting new challenges to pandemic prevention and control. Hence, we review the biological characteristics of the Omicron variant and discuss the current status and possible mechanism of breakthrough infection caused by the Omicron variant in order to provide insights into the prevention and control of the pandemic of SARS-CoV-2

Image_3_Sex hormone-binding globulin exerts sex-related causal effects on lower extremity varicose veins: evidence from gender-stratified Mendelian randomization.tif

BackgroundThe association between serum sex hormones and lower extremity varicose veins has been reported in observational studies. However, it is unclear whether the association reflects a causal relationship. Besides, serum sex hormone-binding globulin (SHBG) has been rarely studied in lower extremity varicose veins. Here, we aim to investigate the association between serum levels of SHBG, testosterone, and estradiol and the risk of lower extremity varicose veins using Mendelian randomization (MR).MethodsWe obtained genome-wide association study summary statistics for serum SHBG levels with 369,002 European participants, serum testosterone levels with 424,907 European participants, serum estradiol levels with 361,194 European participants, and lower extremity varicose veins with 207,055 European participants. First, a univariable MR was performed to identify the causality from SHBG and sex hormone levels to lower extremity varicose veins with several sensitivity analyses being performed. Then, a multivariable MR (MVMR) was performed to further assess whether the causal effects were independent. Finally, we performed a gender-stratified MR to understand the role of genders on lower extremity varicose veins.ResultsGenetically predicted higher serum SHBG levels significantly increased the risk of lower extremity varicose veins in the univariable MR analysis (OR=1.39; 95% CI: 1.13–1.70; P=1.58×10-3). Sensitivity analyses and MVMR (OR=1.50; 95% CI:1.13-1.99; P=5.61×10-3) verified the robustness of the causal relationships. Gender-stratified MR revealed that higher serum SHBG levels were associated with lower extremity varicose veins in both sexes. However, the OR of serum SHBG levels on lower extremity varicose veins risk in females (OR=1.51; 95% CI: 1.23–1.87; P=1.00×10-4) was greater than in males (OR=1.26; 95% CI: 1.04–1.54; P=1.86×10-2).ConclusionsSerum SHBG levels are positively related to lower extremity varicose veins risk in both sexes, especially in females. This may partly explain the higher prevalence of varicose vines among females.</p

Image_2_Sex hormone-binding globulin exerts sex-related causal effects on lower extremity varicose veins: evidence from gender-stratified Mendelian randomization.tif

BackgroundThe association between serum sex hormones and lower extremity varicose veins has been reported in observational studies. However, it is unclear whether the association reflects a causal relationship. Besides, serum sex hormone-binding globulin (SHBG) has been rarely studied in lower extremity varicose veins. Here, we aim to investigate the association between serum levels of SHBG, testosterone, and estradiol and the risk of lower extremity varicose veins using Mendelian randomization (MR).MethodsWe obtained genome-wide association study summary statistics for serum SHBG levels with 369,002 European participants, serum testosterone levels with 424,907 European participants, serum estradiol levels with 361,194 European participants, and lower extremity varicose veins with 207,055 European participants. First, a univariable MR was performed to identify the causality from SHBG and sex hormone levels to lower extremity varicose veins with several sensitivity analyses being performed. Then, a multivariable MR (MVMR) was performed to further assess whether the causal effects were independent. Finally, we performed a gender-stratified MR to understand the role of genders on lower extremity varicose veins.ResultsGenetically predicted higher serum SHBG levels significantly increased the risk of lower extremity varicose veins in the univariable MR analysis (OR=1.39; 95% CI: 1.13–1.70; P=1.58×10-3). Sensitivity analyses and MVMR (OR=1.50; 95% CI:1.13-1.99; P=5.61×10-3) verified the robustness of the causal relationships. Gender-stratified MR revealed that higher serum SHBG levels were associated with lower extremity varicose veins in both sexes. However, the OR of serum SHBG levels on lower extremity varicose veins risk in females (OR=1.51; 95% CI: 1.23–1.87; P=1.00×10-4) was greater than in males (OR=1.26; 95% CI: 1.04–1.54; P=1.86×10-2).ConclusionsSerum SHBG levels are positively related to lower extremity varicose veins risk in both sexes, especially in females. This may partly explain the higher prevalence of varicose vines among females.</p

Image_1_Sex hormone-binding globulin exerts sex-related causal effects on lower extremity varicose veins: evidence from gender-stratified Mendelian randomization.tif

BackgroundThe association between serum sex hormones and lower extremity varicose veins has been reported in observational studies. However, it is unclear whether the association reflects a causal relationship. Besides, serum sex hormone-binding globulin (SHBG) has been rarely studied in lower extremity varicose veins. Here, we aim to investigate the association between serum levels of SHBG, testosterone, and estradiol and the risk of lower extremity varicose veins using Mendelian randomization (MR).MethodsWe obtained genome-wide association study summary statistics for serum SHBG levels with 369,002 European participants, serum testosterone levels with 424,907 European participants, serum estradiol levels with 361,194 European participants, and lower extremity varicose veins with 207,055 European participants. First, a univariable MR was performed to identify the causality from SHBG and sex hormone levels to lower extremity varicose veins with several sensitivity analyses being performed. Then, a multivariable MR (MVMR) was performed to further assess whether the causal effects were independent. Finally, we performed a gender-stratified MR to understand the role of genders on lower extremity varicose veins.ResultsGenetically predicted higher serum SHBG levels significantly increased the risk of lower extremity varicose veins in the univariable MR analysis (OR=1.39; 95% CI: 1.13–1.70; P=1.58×10-3). Sensitivity analyses and MVMR (OR=1.50; 95% CI:1.13-1.99; P=5.61×10-3) verified the robustness of the causal relationships. Gender-stratified MR revealed that higher serum SHBG levels were associated with lower extremity varicose veins in both sexes. However, the OR of serum SHBG levels on lower extremity varicose veins risk in females (OR=1.51; 95% CI: 1.23–1.87; P=1.00×10-4) was greater than in males (OR=1.26; 95% CI: 1.04–1.54; P=1.86×10-2).ConclusionsSerum SHBG levels are positively related to lower extremity varicose veins risk in both sexes, especially in females. This may partly explain the higher prevalence of varicose vines among females.</p

Image_4_Sex hormone-binding globulin exerts sex-related causal effects on lower extremity varicose veins: evidence from gender-stratified Mendelian randomization.tif

BackgroundThe association between serum sex hormones and lower extremity varicose veins has been reported in observational studies. However, it is unclear whether the association reflects a causal relationship. Besides, serum sex hormone-binding globulin (SHBG) has been rarely studied in lower extremity varicose veins. Here, we aim to investigate the association between serum levels of SHBG, testosterone, and estradiol and the risk of lower extremity varicose veins using Mendelian randomization (MR).MethodsWe obtained genome-wide association study summary statistics for serum SHBG levels with 369,002 European participants, serum testosterone levels with 424,907 European participants, serum estradiol levels with 361,194 European participants, and lower extremity varicose veins with 207,055 European participants. First, a univariable MR was performed to identify the causality from SHBG and sex hormone levels to lower extremity varicose veins with several sensitivity analyses being performed. Then, a multivariable MR (MVMR) was performed to further assess whether the causal effects were independent. Finally, we performed a gender-stratified MR to understand the role of genders on lower extremity varicose veins.ResultsGenetically predicted higher serum SHBG levels significantly increased the risk of lower extremity varicose veins in the univariable MR analysis (OR=1.39; 95% CI: 1.13–1.70; P=1.58×10-3). Sensitivity analyses and MVMR (OR=1.50; 95% CI:1.13-1.99; P=5.61×10-3) verified the robustness of the causal relationships. Gender-stratified MR revealed that higher serum SHBG levels were associated with lower extremity varicose veins in both sexes. However, the OR of serum SHBG levels on lower extremity varicose veins risk in females (OR=1.51; 95% CI: 1.23–1.87; P=1.00×10-4) was greater than in males (OR=1.26; 95% CI: 1.04–1.54; P=1.86×10-2).ConclusionsSerum SHBG levels are positively related to lower extremity varicose veins risk in both sexes, especially in females. This may partly explain the higher prevalence of varicose vines among females.</p

Table_1_Sex hormone-binding globulin exerts sex-related causal effects on lower extremity varicose veins: evidence from gender-stratified Mendelian randomization.xlsx

BackgroundThe association between serum sex hormones and lower extremity varicose veins has been reported in observational studies. However, it is unclear whether the association reflects a causal relationship. Besides, serum sex hormone-binding globulin (SHBG) has been rarely studied in lower extremity varicose veins. Here, we aim to investigate the association between serum levels of SHBG, testosterone, and estradiol and the risk of lower extremity varicose veins using Mendelian randomization (MR).MethodsWe obtained genome-wide association study summary statistics for serum SHBG levels with 369,002 European participants, serum testosterone levels with 424,907 European participants, serum estradiol levels with 361,194 European participants, and lower extremity varicose veins with 207,055 European participants. First, a univariable MR was performed to identify the causality from SHBG and sex hormone levels to lower extremity varicose veins with several sensitivity analyses being performed. Then, a multivariable MR (MVMR) was performed to further assess whether the causal effects were independent. Finally, we performed a gender-stratified MR to understand the role of genders on lower extremity varicose veins.ResultsGenetically predicted higher serum SHBG levels significantly increased the risk of lower extremity varicose veins in the univariable MR analysis (OR=1.39; 95% CI: 1.13–1.70; P=1.58×10-3). Sensitivity analyses and MVMR (OR=1.50; 95% CI:1.13-1.99; P=5.61×10-3) verified the robustness of the causal relationships. Gender-stratified MR revealed that higher serum SHBG levels were associated with lower extremity varicose veins in both sexes. However, the OR of serum SHBG levels on lower extremity varicose veins risk in females (OR=1.51; 95% CI: 1.23–1.87; P=1.00×10-4) was greater than in males (OR=1.26; 95% CI: 1.04–1.54; P=1.86×10-2).ConclusionsSerum SHBG levels are positively related to lower extremity varicose veins risk in both sexes, especially in females. This may partly explain the higher prevalence of varicose vines among females.</p

Tri-functional coating to enhance the capacity retention of LiNi0.5Mn1.5O4 for high power lithium ion battery

LiNi0.5Mn1.5O4 is a promising cathode material for high power lithium ion batteries (LIBs) for electric vehicles (EVs) and hybrid electric vehicles (HEVs). For the first time we design a tri-functional coating to improve the cycling performance of LiNi0.5Mn1.5O4. With the designed BiPO4 coating, the capacity retentions of LiNi0.5Mn1.5O4 are largely improved from 84.3% to 93.6% at 0.5 C after 50 cycles and from 80.6% to 96.2% at 10 C after 100 cycles. The tri-functional coating reduces the charge transfer resistance of LiNi0.5Mn1.5O4 cathode and plays a critical role in enhancing the electrochemical performance and lifetime. This strategy provides a new way to modify electrode materials to elevate the performance of LIBs

Surface reduction stabilizes single-crystalline Ni-rich layered cathode for Li-ion batteries

The surface of the layered transition metal oxide cathode plays an important role in its function and degradation. Modification of the surface structure and chemistry is often necessary to overcome the debilitating effect of the native surface. Here, we employ a chemical reduction method using CaI2 to modify the native surface of single-crystalline layered transition metal oxide cathode particles. High-resolution transmission electron microscopy shows the formation of a conformal cubic phase at the particle surface, where the outmost layer is enriched with Ca. The modified surface significantly improves the long-term capacity retention at low rates of cycling, yet the rate capability is compromised by the impeded interfacial kinetics at high voltages. The lack of oxygen vacancy generation in the chemically induced surface phase transformation likely results in a dense surface layer that accounts for the improved electrochemical stability and impeded Li-ion diffusion. This work highlights the strong dependence of the electrode’s (electro)chemical stability and intercalation kinetics on the surface structure and chemistry, which can be further tailored by the chemical reduction method

Li Alginate-Based Artificial SEI Layer for Stable Lithium Metal Anodes

Lithium metal anodes (LMAs) are critical for high-energy-density batteries such as Li-S and Li-O2 batteries. The spontaneously formed solid electrolyte interface on LMAs is fragile, which may not accommodate the cyclic Li plating/stripping. This usually will result in a low coulombic efficiency (CE), short cycle life, and potential safety hazards induced by the uncontrollable growth of lithium dendrites. In this study, we fabricate a Li alginate-based artificial SEI (ASEI) layer that is chemically stable and allows easy Li ion transport on the surface of LMAs, thus enabling the stable operation of lithium metal anodes. Compared to bare LMAs, the ASEI layer-protected LMAs exhibit a more stable Li plating/stripping behavior and present effective dendrite suppression. The symmetric LiLi cells with the ASEI layer-protected LMAs can stably run for 850 and 350 h at current densities of 0.5 and 1 mA cm-2, respectively. Additionally, the LiFePO4Li full cell with the ASEI layer-protected LMA exhibits a capacity retention of about 94.0% coupled with a CE of 99.6% after 1000 cycles at 4 C. We believe that this study of engineering an ASEI brings a new and promising approach to the stabilization of LMAs for high-performance lithium metal batteries